Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abdominal protrusion
acetylcholine
acromegaly
advances in neurology
adverse drug reaction
affective disorders
agitation
akathisia
algorithm
alpha methyldopa hydrazine
Alzheimer's disease
amantadine
amitriptyline
amphetamines
amphetamines, dyskinesia associated with
amygdala
anesthesia, general
anticholinergic drugs
anticholinergic drugs, side effects of
antidepressant
antihistamines
anxiety
apomorphine
aprazolam
arrhythmia, cardiac
aspartate aminotransferase
asterixis
atypical
autonomic dysfunction
axillary nerve
ballismus, bilateral
behavioral disorder
benzodiazepine
bladder dysfunction
bradykinesia
bromocriptine
Brueghel's syndrome
burning paresthesia
buspirone
carbidopa
CAT scan, emission
catechol-o-methyltransferase inhibitor
chest pain
chorea
clonazepam
clozapine
complications
confusion
controversies in neurology
Coombs test, positive
cough
delirium
delusion
dementia
deprenyl
depression
desipramine
diabetes mellitus
diarrhea
dopamine
dopamine agonist
drug abuse
drug addiction
drug holiday
drug induced neurologic disorders
drug interactions
drug withdrawal
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, drug induced
dyspnea
dystonia
dystonia, treatment of
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electroencephalogram, triphasic delta waves
encephalopathy
entacapone
enzyme inhibition
enzyme, serum
epidemiology of neurology
excitotoxin
genetic neurologic disorders
globus pallidus, stimulation
groaning
hallucination
hallucination, visual
haloperidol
hemiballismus
hemidystonia
hunger
hyperthermia
iatrogenic neurologic disorders
imipramine
infusion pump
intellectual deficit
isoniazid
L-dopa
L-dopa, controlled release
L-dopa, delayed treatment in Parkinsonism
L-dopa, drug interactions with and side effects of
L-dopa, enteral infusion, continuous
L-dopa, plasma concentration
L-dopa, potentiators of
Lewy body
Lewy body disease, diffuse
livedo reticularis
liver function enzymes
locus ceruleus, lesion of
lorazepam
manic-depressive
melanoma, malignant
memory
memory, impairment of
mental status, abnormal
mitochondrial disease
monoamine oxidase inhibitors
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MRI
myoclonic jerks
myoclonus
myoclonus, sleep
nausea and vomiting
neuroendocrinology
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic complications of, surgery
neurologic signs
neurologist
neuronal degeneration
neuropathology
nigrostriatal pathway
nortriptyline
olanzapine
ondansetron
oral contraceptives
oral contraceptives, choreiform movements with
orthostatic hypotension
pain
pallidotomy
panic attacks
papaverine
paranoia
paresthesias
Parkinson disease
Parkinson disease, complications, late
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug holiday
Parkinson disease, dystonia with
Parkinson disease, early symptoms
Parkinson disease, fluctuations in
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, pathogenesis of
Parkinson disease, postencephalitic
Parkinson disease, sensory symptoms in
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, young onset
Parkinsonism plus syndrome
Parkinsonism syndrome
parsidol
patient information and support
pergolide
phenothiazine
phenothiazine, dyskinesia associated with
phobias
pramipexole
procyclidine
progressive supranuclear palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychotic behavior
pyridoxine
quetiapine
raphe nuclei
reserpine and reserpine like drugs
reserpine treatment in movement disorder
respirations in CNS disease
respiratory dyskinesias
review article
rigidity
ritalin
ropinirole
selective serotonin reuptake inhibitors
serotonin antagonist
serum alanine aminotransferase
sinemet
single photon emission computed tomography
sleep pathology and physiology
start hesitation
stimulation, deep brain
substantia nigra
subthalamic nucleus
subthalamic nucleus deep brain stimulation
tardive dyskinesia
tolcapone
tonic foot response
torticollis
trazodone
treatment of neurologic disorder
tremor
tremor, thalamic stimulation for suppression of
tricyclic antidepressant
trigeminal neuralgia
vitamin, multiple
vocalizations
Showing articles 400 to 450 of 2466 << Previous Next >>

Benefit of Atrial Pacing in Sleep Apnea Syndrome
NEJM 346:404-412,390,444, Garrigue,S., et al, 2002

Practice Parameter: Initiation of Treatment for Parkinson's Disease: An Evidence-based Review
Neurol 58:11-17, Miyasaki,J.M.,et al, 2002

Mild Therapeutic Hypothermia to Improve the Neurologic Outcome After Cardiac Arrest
NEJM 346:549-556,612,546, The Hypothermia After Cardiac Arrest Study Group, 2002

Cerebrovascular Complication Associated with Pulmonary Vein Ablation
J Cardiovasc Electrophysiol 13:764-767, Kok,L.C.,et al, 2002

Clinical Profile of Stroke in 900 Patients with Hypertrophic Cardiomyopathy
J Am Coll Cardiol 39:301-307, Maron,B.J.,et al, 2002

Hypertrophic Cardiomyopathy A Systematic Review
JAMA 287:1308-1320, Maron, B.J., 2002

Late Cardiopulmonary Complication of Ventriculo-atrial Shunt
Lancet 358:1608,1569, Milton,C.A.,et al, 2001

Spinocerebellar Ataxia Type 2 Presenting as Familial Levodopa-Responsive Parkinsonism
Ann Neurol 50:812-815, Shan,D.,et al, 2001

Effects of Bilateral Subthalamic Nucleus Stimulation on Parkinsonian Gait
Neurol 57:144-146, Stolze,H.,et al, 2001

Asystole Induced by Edrophonium Following Beta Blockade
Neurol 57:739, Okun,M.S.,et al, 2001

Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial
Stroke 32:2333-2337, Saxena,R.,et al, 2001

Right Sylvian Fissure Subarachnoid Hemorrhage Has Electrocardiographic Consequences
Stroke 32:2278-2281, Hirashima,Y.,et al, 2001

Ten-year Follow-up of Three Different Initial Treatments in De-novo PD
Neurol 57:1687-1694, Lees,A.J.,et al, 2001

Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001

Atrial Fibrillation and Stroke
Stroke 32:803-808, Hart,R.G. &Halperin,J.L., 2001

Warfarin Therapy for an Octogenarian who has Atrial Fibrillation
Ann Int Med 134:465-474, Gage,B.F.,et al, 2001

Atrial Fibrillation
NEJM 344:1067-1078, Falk,R.H., 2001

Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001

Systematic Review of Long Term Anticoagulation or Antiplatelet Treatment in Patients with Non-rheumatic Atrial Fibrillation
BMJ 322:321-326, Taylor,F.C.,et al, 2001

Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001

Coexisting Causes of Ischemic Stroke
Arch Neurol 57:1139-1144,1113, Moncayo,J. et al, 2000

Cardiac Arrhythmias and Stroke
Stroke 31:2925-2929, Engstrom,G.,et al, 2000

Syncope
NEJM 343:1856-1862, Kapoor,W.N., 2000

Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000

Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000

Cardiac Involvement in Patients with Acute Neurologic Disease
Arch Int Med 160:3153-3158, Dixit,S.,et al, 2000

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA 284:1931-1938,1971, Parkinson Study Group, 2000

Complications During Apnea Testing in the Determination of Brain Death: Predisposing Factors
Neurol 55:1045-1048, Goudreau,J.L.,et al, 2000

Axial Parkinsonian Symptoms Can Be Improved: The Role of Levodopa and Bilateral Subthalamic Stimulation
JNNP 68:595-600, Bejjani,B.P.,et al, 2000

Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000

Atrial Fibrilation and the Risk of Cerebral White Matter Lesions
Neurol 54:1795-1801, de Leeuw,F.E.,et al, 2000

The Catechol-O-Methyltransferase (COMT) Inhibitor Entacapone Enhances the Pharmacokinetic and Clinical Response to Sinemet CR in Parkinson's Disease
JNNP 68:589-594, Piccinni,P.,et al, 2000

Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000

Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000

Misdiagnosis of Epilepsy: Many Seizure-Like Attacks Have a Cardiovascular Cause
J Am Coll Cardiol 36:181-184, Zaidi,A. et al, 2000

Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000

Atrial Fibrillation Associated with Sumatriptan
BMJ 321:275, Morgan,D.R. et al, 2000

Desmin Myopathy, a Skeletal Myopathy with Cardiomyopathy Caused by Mutations in the Desmin Gene
NEJM 342:770-780, Dalakas,M.C.,et al, 2000

Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000

Cardiac Dysfunction in Neuromuscular Diseases
The Neurologist 6:67-82, Pourmand,R., 2000

Anticoagulation for Chronic Atrial Fibrillation
JAMA 283:2901-2903, Stern,S.,et al, 2000

When Should Heparin be Given to Patients with Atrial Fibrillation-Related Embolic Brain Infarcts?
Arch Neurol 56:1059-1060, Caplan,L.R., 1999

Heparin in Acute Stroke with Atrial Fibrillation, Clinical Relevance of Very Early Treatment
Arch Neurol 56:1098-1102,1059, Chamorro,A.,et al, 1999

Immediate-Release and Controlled-Release Carbidopa/Levodopa in PD, A 5-Year Randomized Multicenter Study
Neurol 53:1012-1019, Koller,W.C.,et al, 1999

Primary Prevention of Arterial Thromboembolism in Non-Rheumatic Atrial Fibrillation in Primary Care:Randomised Controlled Trial Comparing Two Intensities of Coumarin with Aspirin
BMJ 319:958-964, Hellemons,B.S.P.,et al, 1999

Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation:A Meta-Analysis
Ann Int Med 131:492-501,537, Hart,R.G.,et al, 1999

Autosomal Dominant Myofibrillar Myopathy with Arrhythmogenic Right Ventricular Cardiomyopathy Linked to Chromosome 10q
Ann Neurol 46:684-692,681, Melberg,A.,et al, 1999

Coma in a Park
Lancet 354:1090, Pilz,B.,et al, 1999

Myocardial Injury and Left Ventricular Performance After Subarachnoid Hemorrhage
Stroke 30:780-786, Mayer,S.A.,et al, 1999

Muscle Pain after Exercise
Lancet 353:1062, Nielen,C.&Mazzone,P., 1999



Showing articles 400 to 450 of 2466 << Previous Next >>